FibroBiologics Inc’s recent filing unveils that its Chief Scientific Officer Khoja Hamid acquired Company’s shares for reported $16800.0 on May 27 ’25. In the deal valued at $0.84 per share,20,000 shares were bought. As a result of this transaction, Khoja Hamid now holds 31,250 shares worth roughly $10625.0.
Rodman & Renshaw initiated its FibroBiologics Inc [FBLG] rating to a Buy in a research note published on December 12, 2024; the price target was $12. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Maxim Group began covering FBLG with “Buy” recommendation on September 24, 2024.
Price Performance Review of FBLG
On Tuesday, FibroBiologics Inc [NASDAQ:FBLG] saw its stock fall -5.41% to $0.34. Over the last five days, the stock has gained 3.24%. FibroBiologics Inc shares have fallen nearly -90.54% since the year began. Nevertheless, the stocks have fallen -83.12% over the past one year. While a 52-week high of $3.76 was reached on 01/07/25, a 52-week low of $0.32 was recorded on 11/04/25.
Levels Of Support And Resistance For FBLG Stock
The 24-hour chart illustrates a support level at 0.3235, which if violated will result in even more drops to 0.3093. On the upside, there is a resistance level at 0.3484. A further resistance level may holdings at 0.3591.
How much short interest is there in FibroBiologics Inc?
A steep rise in short interest was recorded in FibroBiologics Inc stocks on 2025-10-31, growing by 0.85 million shares to a total of 1.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 0.97 million shares. There was a rise of 46.68%, which implies that there is a positive sentiment for the stock.
